We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

3D Culture on Lysate Gel Scaffolds Prompt Microvascular Network Formation

By LabMedica International staff writers
Posted on 08 Jun 2016
Print article
Image: Lab-engineered human capillaries (in green) derived from stem cells are \"making contact\" with the sprouts protruding from a rat aorta (in red) (Photo courtesy of Tiago Fortunato, University of Bath).
Image: Lab-engineered human capillaries (in green) derived from stem cells are \"making contact\" with the sprouts protruding from a rat aorta (in red) (Photo courtesy of Tiago Fortunato, University of Bath).
Use of human platelet lysate gel as the support material for the three-dimensional culture of endothelial progenitor cells (EPCs) enables the formation of a complete microvascular network in vitro.

Existing extracellular matrix (ECM) preparations used for in vitro growth of blood vessels require addition of high concentrations of recombinant growth factors and allow only limited formation of capillary-like structures.

Investigators at the University of Bath (United Kingdom) developed an improved blood vessel culture method based on a lysate gel prepared from human platelets (hPLG). This novel extracellular matrix preparation was able to support the proliferation of endothelial colony forming cells (ECFCs) in two-dimensional cultures and the formation of a complete microvascular network in vitro in three-dimensional cultures.

Additional advantages of this approach over existing extracellular matrices were the absence of any animal product in the hPLG composition and the possibility of obtaining hPLG from patients to generate homologous scaffolds for re-implantation.

In a paper published in the May 4, 2016, online edition of the journal Scientific Reports the investigators described the use of hPLG as an animal product-free and patient-specific tool to amplify, differentiate, and deliver ECFCs for regenerative medicine applications. They characterized the structure and composition of hPLG, and demonstrated the ability of this human-derived material to promote ECFC amplification and stimulate the formation of ECFC-driven microvascular networks in vitro. They also characterized the morphology and properties of the microvascular networks obtained in vitro.

Contributing author Dr. Paul De Bank, senior lecturer in pharmaceutics at the University of Bath, said, "By embedding EPCs in a gel derived from platelets, both of which can be isolated from the patient's blood, we have demonstrated the formation of a network of small vessels. What is more, the gel contains a number of different growth factors, which can induce existing blood vessels to infiltrate the gel and form connections with the new structures. Combining tissue-specific cells with this EPC-containing gel offers the potential for the formation of fully vascularized, functional tissues or organs, which integrate seamlessly with the patient. This discovery has the potential to accelerate the development of regenerative medicine applications."

Related Links:
University of Bath

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more